# US 2026/0130755 A1 · Stabilization of Collagen Scaffolds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0130755 A1
- Document ID: US20260130755A1
- Status: Published application
- Kind: A1
- Application number: 19/261,082
- Filed: 2025-07-07
- Published: 2026-05-14
- Earliest claimed: 2018-07-02
- Assignees: Gebauer- Klopotek Patent Verwaltungs Ug
- Applicants: Gebauer-Klopotek Patent Verwaltungs-UG
- Inventors: Peter J. KLOPOTEK
- Web page: https://patentgrep.com/patent/US20260130755A1

## CPC

- A61F 2/142: {Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue}
- A61F 9/00827: {Refractive correction, e.g. lenticle}
- A61F 9/00836: {Flap cutting}
- A61F 2009/00872: {Cornea}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Shape-stabilized collagen scaffolds and methods of obtaining such scaffolds are disclosed. Stroma can be harvested, for example, from human or porcine corneal stroma and shaped during excision or in a separate step after excision. Following shaping (and preferably decellularization), the excised stroma portion is subject to pressure, force or vacuum to reduce fluid content and then irradiated or otherwise treated to induce crosslinking of collagen chains or fibrils. In one embodiment, the scaffold can be compacted by removing some or all of the water from the scaffold, and rehydrating the scaffold in a controlled manner (e.g., in a mold or other confining space) such that the scaffold takes a desired compacted shape; and then crosslinking at least a portion of the scaffold to mechanically strengthen it and inhibit subsequent swelling. Various sources of energy can be employed to induce crosslinking of collagen including, for example, ultraviolet (UV) radiation. The scaffolds can also be selectively densified or patterned. The invention is particularly useful in forming stable lenticules of enhanced stiffness and sufficient optical clarity for intracorneal implantation in additive ocular surgery.

## Claims

### Claim 1

A method of forming a scaffold from donor corneal stroma excised from a central region of a donor corneal source comprising:
decellularizing donor corneal stroma to obtain a scaffold;
removing fluid present in the scaffold; and
crosslinking at least a portion of the scaffold to inhibit subsequent swelling.

### Claim 2 (depends on 1)

The method of claim 1 wherein the method further comprises removing water from the scaffold and the permitting controlled rehydration in a confining space to achieve a desired density and/or stiffness.

### Claim 3 (depends on 2)

The method of claim 2 wherein the step of removing fluid further comprises applying pressure, acceleration (e.g., centrifugal force). a vacuum to the scaffold, or freeze drying the scaffold.

### Claim 4 (depends on 1)

The method of claim 1 wherein the step of decellularizing further comprises treating the scaffold with a chemical decellularizing agent and optionally wherein the step of decellularizing occurs before or after removing water, or before or after crosslinking.

### Claim 5 (depends on 1)

The method of claim 1 wherein the step of decellularizing further comprises removing cellular debris from the scaffold with a detergent or a surfactant;

### Claim 6 (depends on 5)

The method of claim 5 wherein the method further comprises enzymatically removing or conformationally altering at least one immunogenic epitope of the scaffold.

### Claim 7 (depends on 1)

The method of claim 1 wherein the steps of removing fluid from the scaffold and crosslinking the scaffold result in at least a portion of the scaffold having a collagen density greater than the original excised stroma.

### Claim 8 (depends on 1)

The method of claim 1 wherein the step of removing fluid from the scaffold further comprises compressing the scaffold whereby at least a portion of the compressed and crosslinked scaffold has a composition of at least 15 percent collagen, or least 30 percent collagen, or at least 25 percent collagen, or at least 60 percent collagen.

### Claim 9 (depends on 1)

The method of claim 1 wherein the step of crosslinking further comprises exposing at least a portion of the compressed scaffold to a crosslinking promoter or actinic radiation.

### Claim 10 (depends on 1)

The method of claim 1 wherein the step of crosslinking further comprises exposing at least a portion of the compressed scaffold to radiation to induce crosslinking by peptide bond formation between collagen fibrils with or without the assistance of a crosslinking promoter or other energy mediating agent and optionally wherein the step of crosslinking the scaffold further comprises irradiating the scaffold with ultraviolet radiation, x-rays, gamma radiation or an electron beam.

### Claim 11 (depends on 10)

The method of claim 10 wherein the step of crosslinking further comprises exposing at least a portion of the compressed scaffold to ultraviolet radiation by direct exposure, or by exposure at a grazing incidence angle or via an evanescent waveguide coupled to a surface of the scaffold.

### Claim 12 (depends on 10)

The method of claim 10 wherein the step of crosslinking further comprises selectively exposing a surface portion of the compressed scaffold to a radiation such that the surface portion exhibits greater crosslinking and higher collagen density than a bulk region of the scaffold.

### Claim 13 (depends on 10)

The method of claim 10 wherein the step of crosslinking further comprises applying sufficient radiation to inactivate any microbial agents and/or sterilize the scaffold.

### Claim 14 (depends on 1)

The method of claim 1, wherein the scaffold is configured for use as an implantable lenticule having a lenticule body, an anterior surface and a posterior surface that give the lenticule a final desired shape.

### Claim 15 (depends on 1)

The method of claim 1, wherein the step of crosslinking further comprises treating at least a portion of the posterior surface of the lenticule with a crosslinking agent or by selective application of patterning radiation to promote adherence of the lenticule to a stromal bed when implanted into a patient's stromal bed.

### Claim 16 (depends on 1)

The method of claim 1 wherein the step of crosslinking further comprises enhancing the optical clarity of the scaffold.

### Claim 17 (depends on 16)

The method of claim 16 wherein the scaffold exhibits a scattering angle, theta, of less than 4 arcminutes.

### Claim 18 (depends on 17)

The method of claim 17 wherein the lenticule exhibits a scattering angle, theta, of less than 3 arcminutes or less than 2 arcminutes, or less than 1 arcminute.

### Claim 19 (depends on 1)

The method of claim 1 wherein the scaffold exhibits a modulus stiffness, μ, greater than 1.2×105 Pa.

### Claim 20 (depends on 1)

The method of claim 1 wherein the scaffold exhibits a modulus stiffness, μ, greater than 1.4×105 Pa, or greater than 1.6×105 Pa, or greater than 1.8×105 Pa, or greater than 2×105 Pa, or greater than 3×105 Pa, or greater than 5×105 Pa, or greater than 8×105 Pa, or greater than 1×106 Pa, or greater than 2×105 Pa or greater than 2.6×106 Pa, or greater than 3×106 Pa, or greater than 4×106 Pa.

### Claim at position 21

21-51. (canceled)
